Rectal Cancer MRI: Post Treatment Evaluation-- Gaurav Khatri, MD & Katrina McGinty, MD (SABI '19)

See the full SCBT-MR/SABI 42nd Annual Course in online streaming format at www.Meetings-By-Mail.com!
Meetings By Mail presents this lecture from the SCBT-MR/SABI 42nd Annual Course. This presentation is from the Conference's session on Hepatobiliary and Pancreas Imaging.

Пікірлер: 8

  • @balaji4057
    @balaji40572 жыл бұрын

    Split scar post rx

  • @EveryDooDarnDiddlyDay
    @EveryDooDarnDiddlyDay11 ай бұрын

    Yeah...they cured this already

  • @Johnny-ip4mk

    @Johnny-ip4mk

    7 ай бұрын

    What do you mean?

  • @EveryDooDarnDiddlyDay

    @EveryDooDarnDiddlyDay

    7 ай бұрын

    @@Johnny-ip4mk Dostarlimab, monoclonal antibodies, Immunotherapy.

  • @EveryDooDarnDiddlyDay

    @EveryDooDarnDiddlyDay

    7 ай бұрын

    @@Johnny-ip4mk kzread.info/dash/bejne/i5l7zMann9XPqpc.htmlsi=U-dAjVf4MQ8GsPrz

  • @Johnny-ip4mk

    @Johnny-ip4mk

    7 ай бұрын

    @@EveryDooDarnDiddlyDay No surgery?

  • @EveryDooDarnDiddlyDay

    @EveryDooDarnDiddlyDay

    7 ай бұрын

    @@Johnny-ip4mk Just one pill a week.

  • @rajivkapur78
    @rajivkapur783 жыл бұрын

    Only TRG needs to be given or we can actually restage from T3 to T2 based on response? Need clarification if in a T3 disease, post treatment all the tumor is T2 hypo suggestive of fibrosis, so should it remain T3 disease with 1/2 TRG or it can be downgraded to T2.